Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-9957
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count ; volume:5 ; number:1 ; day:5 ; month:9 ; year:2016 ; pages:1-6 ; date:12.2016
Infectious diseases of poverty ; 5, Heft 1 (5.9.2016), 1-6, 12.2016
- Creator
-
Bigna, Jean Joel R.
- Contributor
-
Plottel, Claudia S.
Koulla-Shiro, Sinata
SpringerLink (Online service)
- DOI
-
10.1186/s40249-016-0179-9
- URN
-
urn:nbn:de:1111-201609071769
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bigna, Jean Joel R.
- Plottel, Claudia S.
- Koulla-Shiro, Sinata
- SpringerLink (Online service)
Other Objects (12)
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy
Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy
Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy